After graduating with a BSc degree in Biological Sciences and a PhD in Molecular Biology, Dr Colin Story started his career at Amersham plc (now GE Healthcare) progressing through Product Development and Project Management roles to head a global commercial role with full P&L accountability for a £20m product portfolio.

In 2005 he joined Isis Innovation Ltd, establishing a Business Development team to manage over 200 medical science innovations emanating from Oxford University. In 2011 he was invited to join OrganOx Ltd as Operations Director, seeing the business take its class III medical device from prototype through to successful completion of first in human clinical trials. Dr Story co-founded OxSonics in 2013 and served as CEO from January 2014 through to January 2022. Under his leadership, a total of £25m was raised across three financing rounds, and OxSonics’ proprietary ‘SonoTran’ platform technology transitioned into clinical use. He built out the executive team of 30 and the board. He also led OxSonics through corporate restructuring in 2016 to form sister company OrthoSon Limited, raising £1m seed capital and running the business until a CEO was hired in 2018. He served on the board as a Non-Executive Director for 6 years. He lectures University of Oxford post-graduate students on the topics of fundraising and building a business and he also supports founders and CEO’s in his network either as a NED or on a consultancy basis.